Analyst Reco. Sabra Health Care REIT, Inc.

Equities

SBRA

US78573L1061

Market Closed - Nasdaq Other stock markets 04:00:01 2024-05-31 pm EDT			5-day change	1st Jan Change
14.59 ^USD	+1.46%		+1.18%	+2.24%

May. 15	Scotiabank Raises Sabra Health Care REIT's Price Target to $15 From $14, Maintains Sector Perform Rating	MT
May. 09	Transcript : Sabra Health Care REIT, Inc., Q1 2024 Earnings Call, May 09, 2024

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Scotiabank Raises Sabra Health Care REIT's Price Target to $15 From $14, Maintains Sector Perform Rating	May. 15	MT
Deutsche Bank Initiates Coverage on Sabra Health Care REIT With Buy Rating, $21 Price Target	Jan. 30	MT
Mizuho Adjusts Sabra Health Care REIT's Price Target to $17 From $15, Maintains Buy Rating	Jan. 03	MT
Stifel Increases Price Target on Sabra Health Care REIT to $16 From $14, Maintains Buy Rating	Nov. 07	MT
BMO Capital Downgrades Sabra Health Care REIT to Market Perform From Outperform, $16 Price Target	23-10-17	MT
Wells Fargo Upgrades Sabra Health Care REIT to Equalweight From Underweight, Raises Price Target to $15 From $11	23-10-16	MT
BofA Securities Upgrades Sabra Health Care REIT to Buy From Neutral	23-10-10	MT
Wedbush Starts Sabra Health Care REIT at Outperform With $16 Price Target	23-10-03	MT
Jefferies Upgrades Sabra Health Care REIT to Buy From Hold, Adjusts Price Target to $15 From $11	23-09-20	MT
BofA Securities Upgrades Sabra Health Care REIT to Neutral From Underperform, Adjusts Price Target to $14 From $11	23-08-11	MT
Citigroup Adjusts Price Target on Sabra Health Care REIT to $12.50 From $11, Maintains Neutral Rating	23-07-14	MT
Barclays Cuts Price Target on Sabra Health Care REIT to $13 From $15, Maintains Equalweight Rating	23-04-25	MT
Wells Fargo Starts Sabra Health Care REIT at Underweight With $11 Price Target	23-04-20	MT
Truist Securities Adjusts Price Target on Sabra Health Care REIT to $13 From $14, Maintains Buy Rating	23-03-29	MT
JMP Securities Downgrades Sabra Health Care REIT to Market Perform From Market Outperform	22-12-13	MT
BofA Securities Downgrades Sabra Health Care REIT to Underperform From Neutral, Adjusts Price Target to $13 From $15	22-11-14	MT
Baird Downgrades Sabra Health Care REIT to Neutral From Outperform	22-10-10	MT
Berenberg Bank Adjusts Price Target on Sabra Health Care REIT to $17 From $15, Maintains Buy Rating	22-08-09	MT
Citigroup Adjusts Price Target for Sabra Health Care REIT to $14.50 From $15, Maintains Neutral Rating	22-07-08	MT
Jefferies Downgrades Sabra Health Care REIT to Hold from Buy, Adjusts Price Target to $14 from $15	22-06-30	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Sabra Health Care REIT, Inc.

Equities

SBRA

US78573L1061

Analyst Reco.

Filters